muscular calf vein thromboses
Conditions
Interventions
Control group:Early postoperative mobilization
Experimental group:Ultra-early postoperative mobilization
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age > 18 years old, male or female; 2. Patients diagnosed with primary superficial varicose veins of the lower extremity, who had not undergone surgical treatment before, and was hospitalized for surgical treatment of the saphenous vein under monitored anesthesia care (the indications, methods and postoperative treatment should be referred to the "Diagnosis and Treatment Standards for Common Venous Diseases (2022 Edition)" from the Chinese Medical Doctor Association); 3. No anticoagulation or antiplatelet therapy was performed before surgery, and thrombosis and coagulation tests were normal; 4. Walk into the ward when admission; 5. Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Any venous thrombosis confirmed by previous or preoperative imaging, or the D-dimer > 0.05 mg/L 1 week prior to surgery., or fibrinogen degradation product > 5 mg/L 1 week prior to surgery; 2. Any disorders of coagulation mechanism that has not been corrected, or taking anticoagulant or antiplatelet drugs for any reason; 3. Any other surgery, intervention, sclerotic closure therapy or hospitalization within 1 month before the varicose veins surgery; 4. Except primary superficial varicose veins of the lower extremities, any cardiovascular disease that interferes with general physical activity, or New York College of Cardiology (NYHA) cardiac function class >= II, or has a history of chronic respiratory disease requiring continuous oxygen; 5. Assessed at high risk of falling (age > 65; critically ill; a history of falls; cognitive dysfunction; mobility/balance impairments; a history of vertigo/syncope) and a further Morse fall scale point >= 45; 6. Any condition that, in the opinion of the investigator, is inappropriate to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of muscular calf vein thromboses; | — |
Secondary
| Measure | Time frame |
|---|---|
| Elevated postoperative D-dimer;Elevated postoperative fibrin(-ogen) degradation products;Venous clinical severity score.;Incidence of postoperative bleeding and incidence of postoperative severe bleeding;Incidence of postoperative wound infection;Safety metrics; | — |
Countries
China
Contacts
Public ContactYang Shiwei
The First Affiliated Hospital of Army Medical University
Outcome results
None listed